Osteochondritis dissecans tali M93.2
Conditions
Interventions
Group 1: Clinical trial with evaluation of the Clinical outcome, pain, quality of life in patients with osteochondral lesions of the talus and Surgery from 2007 till 2012 treated with autologous spo
Sponsors
Universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients (male and female) between 18 and 65 years with osteochondritis dissecans tali and Surgery between 2007 and 2012 (autologous spongiosa grafts and autologous matrix induced chondrogenesis).
Exclusion criteria
Exclusion criteria: younger than 18, older than 65, patients who cannot give their consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AOFAS, FFI Scores (concerning Pain, quality of Life) in Patients treated with autologous spongiosa grafts and autologous matrix induced chondrogenesis in osteochondral lesions of the talus. Point in time of evaluation: 2nd quarter of 2013 (follow-up examination at least one year postoperative). | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS (Pain), complications after autologous spongiosa grafts and autologous matrix induced chondrogenesis in osteochondral lesions of the talus. Point in time of evluation: 2nd quarter of 2013 (follow-up examination). | — |
Countries
Germany
Contacts
Public ContactEva Johanna Hübner
Universitätskliinikum Freiburg Department Chirurgie Klinik für Orthopädie und Unfallchirurgie
Outcome results
None listed